Glass and electronic component manufacturer Corning (NYSE:GLW) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 16% year on year to $3.45 billion. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $3.85 billion at the midpoint, or 5% above analysts’ estimates. Its non-GAAP profit of $0.54 per share was 5.4% above analysts’ consensus estimates.
HR outsourcing provider Insperity (NYSE:NSP) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 3.4% year on year to $1.86 billion. Its non-GAAP profit of $1.57 per share was 22.4% below analysts’ consensus estimates.
Global pharmaceutical company Pfizer (NYSE:PFE) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 7.8% year on year to $13.72 billion. The company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.7% below analysts’ estimates. Its non-GAAP profit of $0.92 per share was 35.2% above analysts’ consensus estimates.
Tobacco company Altria (NYSE:MO) announced better-than-expected revenue in Q1 CY2025, with sales up 11.5% year on year to $5.26 billion. Its non-GAAP profit of $1.23 per share was 3.5% above analysts’ consensus estimates.
Trucking company PACCAR (NASDAQ:PCAR) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 16% year on year to $6.91 billion. Its non-GAAP profit of $1.46 per share was 7.5% below analysts’ consensus estimates.
Data backup provider Commvault (NASDAQ:CVLT) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 23.2% year on year to $275 million. Guidance for next quarter’s revenue was better than expected at $268 million at the midpoint, 1.8% above analysts’ estimates. Its non-GAAP profit of $1.03 per share was 11% above analysts’ consensus estimates.
Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.4% year on year to $169.2 million. The company’s full-year revenue guidance of $707.5 million at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $0.39 per share was 11.4% above analysts’ consensus estimates.
UPS stock rises after beating Q1 2025 earnings expectations with $21.55B revenue and $1.49 EPS. Company plans strategic cost cuts and network reconfiguration.
Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 7.5% year on year to $168 million. On the other hand, the company’s full-year revenue guidance of $753 million at the midpoint came in 2% above analysts’ estimates. Its non-GAAP loss of $0 per share was in line with analysts’ consensus estimates.
Packaged foods company Kraft Heinz (NASDAQ:KHC) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 6.4% year on year to $6.00 billion. Its non-GAAP profit of $0.62 per share was 2.7% above analysts’ consensus estimates.
